Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin for VTE Prophylaxis in Pancreatic Cancer
NCT00966277Phase 4Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2010
- Primary completion
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dalteparin in venous thromboembolism (VTE), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2010; status: completed.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00966277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966277.